Literature DB >> 500942

Circulatory defects during phenformin lactic acidosis.

M A Latif, M H Weil.   

Abstract

Detailed hemodynamic and metabolic studies were performed during the course of phenformin related lactic acidosis in two patients. Arterial blood lactate was increased to 11.5 and 26.1 mM/L and arterial blood pH was reduced to 7.05 and 6.80 units, respectively. A marked reduction in cardiac indices (0.94 and 1.15 L/min/m2), stroke volume, and stroke work were observed, with either normal or increased arterial resistance. Mild increases in pulmonary artery systolic pressure (50/11), 45/25 mmHg) were observed, but necropsy in both cases disclosed no evidence of pulmonary vascular obstruction. In the absence of increases in central venous and pulmonary artery wedge pressure, a cardiac failure was excluded as primary cause of the low output state. Hypovolemia was excluded on the basis of radioisotope dilution measurements of plasma volume and red cell mass and no increase in cardiac output followed volume expansion. Oxygen extraction from blood was not grossly impaired. These observations indicate that phenformin-related lactic acidosis may evolve as a circulatory defect characteristic of shock in which oxygen delivery rather than oxygen utilization is impaired. The hemodynamic defect is best explained by a defect in the intravascular distribution of blood volume.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500942     DOI: 10.1007/bf01683195

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  36 in total

1.  Depression of human myocardial contractility with "respiratory" and "metabolic" acidosis.

Authors:  H E Cingolani; S L Faulkner; A R Mattiazzi; H W Bender; T P Graham
Journal:  Surgery       Date:  1975-03       Impact factor: 3.982

2.  The effect of changes in hydrogen ion concentration on the pulmonary circulation.

Authors:  E H BERGOFSKY; D E LEHR; A P FISHMAN
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

3.  Action of phenethylbiguanide, a hypoglycemic agent, on tricarboxylic acid cycle.

Authors:  G UNGAR; S PSYCHOYOS; H A HALL
Journal:  Metabolism       Date:  1960-01       Impact factor: 8.694

4.  Chemical control of the distribution of the pulmonary blood flow.

Authors:  G LILJESTRAND
Journal:  Acta Physiol Scand       Date:  1958-12-15

5.  The role of pH in myocardial contractility.

Authors:  H H LEVEEN; G FALK; I LUSTRIN; A E HELFT
Journal:  Surgery       Date:  1962-03       Impact factor: 3.982

6.  Treatment of circulatory shock. Use of sympathomimetic and related vasoactive agents.

Authors:  M H Weil; H Shubin; R Carlson
Journal:  JAMA       Date:  1975-03-24       Impact factor: 56.272

7.  Myocardial ischemia and cell acidosis: Modification by alkali and the effects on ventricular function and cation composition.

Authors:  T J Regan; R M Effros; B Haider; H A Oldewurtel; P O Ettinger; S S Ahmed
Journal:  Am J Cardiol       Date:  1976-03-31       Impact factor: 2.778

8.  Effect of extracellular pH on function and metabolism of isolated perfused rat heart.

Authors:  L Opie
Journal:  Am J Physiol       Date:  1965-12

9.  Effects of changes of pH and of carbon dioxide tension on left ventricular performance.

Authors:  M L Ng; M N Levy; H A Zieske
Journal:  Am J Physiol       Date:  1967-07

10.  LACTICACIDOSIS: A CLINICALLY SIGNIFICANT ASPECT OF SHOCK.

Authors:  D I PERETZ; M MCGREGOR; J B DOSSETOR
Journal:  Can Med Assoc J       Date:  1964-03-14       Impact factor: 8.262

View more
  2 in total

1.  Circulatory failure in acute pulmonary embolism.

Authors:  Y Ozier; O Dubourg; J C Farcot; M Bazin; F Jardin; A Margairaz
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

Review 2.  Treatment of acute metabolic acidosis: a pathophysiologic approach.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Nat Rev Nephrol       Date:  2012-09-04       Impact factor: 28.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.